| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,552 |
9,888 |
$897K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,135 |
9,485 |
$541K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,222 |
3,179 |
$101K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,078 |
1,034 |
$89K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
970 |
964 |
$72K |
| 90834 |
Psychotherapy, 45 minutes with patient |
757 |
442 |
$54K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
719 |
668 |
$50K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
572 |
561 |
$46K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
479 |
473 |
$35K |
| 99215 |
Prolong outpt/office vis |
198 |
193 |
$32K |
| X5622 |
|
1,178 |
1,104 |
$31K |
| 92340 |
Fitting of spectacles, except for aphakia; monofocal |
1,215 |
1,208 |
$29K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
5,497 |
5,347 |
$27K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
375 |
372 |
$26K |
| 36415 |
Collection of venous blood by venipuncture |
6,149 |
5,811 |
$25K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
837 |
802 |
$20K |
| 92015 |
Determination of refractive state |
1,513 |
1,493 |
$19K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
171 |
164 |
$16K |
| 99188 |
|
1,525 |
1,502 |
$13K |
| 92551 |
|
1,984 |
1,958 |
$13K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
387 |
356 |
$12K |
| 99205 |
Prolong outpt/office vis |
58 |
52 |
$10K |
| 80061 |
Lipid panel |
724 |
708 |
$9K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
104 |
104 |
$7K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
638 |
629 |
$7K |
| 90686 |
|
1,845 |
1,810 |
$6K |
| V2020 |
Frames, purchases |
168 |
149 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
554 |
540 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
38 |
38 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
118 |
116 |
$4K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
502 |
495 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
225 |
224 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
103 |
101 |
$3K |
| 81514 |
|
12 |
12 |
$3K |
| 80053 |
Comprehensive metabolic panel |
319 |
310 |
$3K |
| 96131 |
|
12 |
12 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
326 |
304 |
$2K |
| 99177 |
|
306 |
303 |
$2K |
| 86003 |
|
40 |
40 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
52 |
51 |
$1K |
| 99173 |
|
1,481 |
1,460 |
$1K |
| 96130 |
|
12 |
12 |
$1K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
12 |
12 |
$1K |
| 90656 |
|
158 |
155 |
$913.14 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
13 |
13 |
$904.85 |
| V2784 |
Lens, polycarbonate or equal, any index, per lens |
50 |
25 |
$692.76 |
| 92567 |
|
66 |
66 |
$681.69 |
| 80050 |
General health panel |
13 |
13 |
$666.47 |
| 96127 |
|
197 |
193 |
$665.92 |
| 82728 |
|
61 |
60 |
$622.43 |
| 0064A |
|
17 |
16 |
$580.14 |
| 90832 |
Psychotherapy, 30 minutes with patient |
12 |
12 |
$528.36 |
| 85027 |
|
79 |
78 |
$490.96 |
| 87481 |
|
13 |
13 |
$452.36 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
13 |
13 |
$452.36 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
12 |
12 |
$264.60 |
| 90651 |
|
33 |
33 |
$257.13 |
| 90670 |
|
252 |
249 |
$208.23 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
53 |
51 |
$205.42 |
| 86803 |
|
14 |
14 |
$186.98 |
| 86780 |
|
12 |
12 |
$145.44 |
| 87081 |
|
25 |
24 |
$90.92 |
| 87210 |
|
15 |
14 |
$83.05 |
| 36416 |
|
37 |
37 |
$60.10 |
| 81001 |
|
14 |
13 |
$42.42 |
| 85018 |
|
13 |
13 |
$32.25 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
32 |
31 |
$0.00 |
| 90707 |
|
27 |
27 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
12 |
12 |
$0.00 |
| 90633 |
|
38 |
38 |
$0.00 |
| 90715 |
|
12 |
12 |
$0.00 |
| 90734 |
|
33 |
33 |
$0.00 |
| 90647 |
|
156 |
154 |
$0.00 |
| 90716 |
|
25 |
25 |
$0.00 |
| 90723 |
|
167 |
164 |
$0.00 |
| 90677 |
|
129 |
126 |
$0.00 |